Option Care Health, Inc. $OPCH Shares Bought by Raymond James Financial Inc.

Raymond James Financial Inc. grew its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 110.7% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 184,074 shares of the company’s stock after acquiring an additional 96,719 shares during the quarter. Raymond James Financial Inc. owned about 0.11% of Option Care Health worth $6,433,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Compass Wealth Management LLC grew its holdings in shares of Option Care Health by 8.9% in the first quarter. Compass Wealth Management LLC now owns 166,078 shares of the company’s stock valued at $5,804,000 after purchasing an additional 13,600 shares during the period. Bessemer Group Inc. grew its stake in shares of Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock valued at $54,000 after buying an additional 599 shares during the period. Principal Financial Group Inc. increased its holdings in shares of Option Care Health by 1.4% during the 1st quarter. Principal Financial Group Inc. now owns 485,871 shares of the company’s stock worth $16,981,000 after buying an additional 6,616 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its position in shares of Option Care Health by 25.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company’s stock valued at $289,000 after buying an additional 1,691 shares during the period. Finally, GAMMA Investing LLC raised its position in shares of Option Care Health by 307.1% during the 1st quarter. GAMMA Investing LLC now owns 3,192 shares of the company’s stock valued at $112,000 after buying an additional 2,408 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on OPCH. JMP Securities raised their target price on Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research note on Thursday, July 31st. Citigroup reissued an “outperform” rating on shares of Option Care Health in a research report on Thursday, July 31st. Finally, Barrington Research restated an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $35.75.

Option Care Health Trading Up 1.7%

Shares of NASDAQ OPCH opened at $28.93 on Thursday. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $4.70 billion, a PE ratio of 23.14, a PEG ratio of 1.75 and a beta of 0.82. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The stock has a fifty day simple moving average of $29.42 and a 200-day simple moving average of $31.59.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.Option Care Health’s revenue was up 15.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, equities analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Buying and Selling

In other Option Care Health news, Director Timothy P. Sullivan acquired 20,000 shares of the company’s stock in a transaction that occurred on Thursday, August 21st. The stock was purchased at an average price of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the acquisition, the director owned 49,229 shares of the company’s stock, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The shares were acquired at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the purchase, the director owned 375,390 shares in the company, valued at $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.